Kuljeet Singh

Prof. Kuljeet Singh

Computer Science, Christ University, Delhi, India
orcid
Assistant Professor, Department of Computer Science, School ...

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Chaos, Solitons & Fractals
Verified
Journal Article
Closed access
SSSourabh Shastri
Sourabh Shastri
Kuljeet SinghKuljeet Singh
Kuljeet Singh
SKSachin Kumar
Sachin Kumar
PKParamjit Kour
Paramjit Kour
VMVibhakar Mansotra
Vibhakar Mansotra


3 January 2021 in International Journal of Information Technology
Verified
Journal Article
Closed access
PDF file
SSSourabh Shastri
Sourabh Shastri
Kuljeet SinghKuljeet Singh
Kuljeet Singh
SKSachin Kumar
Sachin Kumar
PKParamjit Kour
Paramjit Kour
VMVibhakar Mansotra
Vibhakar Mansotra

11 June 2022 in International Journal of Imaging Systems and Technology
Verified
Journal Article
Open access
SKSachin Kumar
Sachin Kumar
SSSourabh Shastri
Sourabh Shastri
SMShilpa Mahajan
Shilpa Mahajan
Kuljeet SinghKuljeet Singh
Kuljeet Singh
SGSurbhi Gupta
Surbhi Gupta
VMVibhakar Mansotra
Vibhakar Mansotra
The syndrome called COVID‐19 which was firstly spread in Wuhan, China has already been declared a globally “Pandemic.” To stymie the further spread of the virus at an early stage, detection needs to be done. Artificial Intelligence‐based deep learning models have gained much popularity in the detection of many diseases within the confines of biomedical sciences. In this paper, a deep neural network‐based “LiteCovidNet” model is proposed that detects COVID‐19 cases as the binary class (COVID‐19, Normal) and the multi‐class (COVID‐19, Normal, Pneumonia) bifurcated based on chest X‐ray images of the infected persons. An accuracy of 100% and 98.82% is achieved for binary and multi‐class classification respectively which is competitive performance as compared to the other recent related studies. Hence, our methodology can be used by health professionals to validate the detection of COVID‐19 infected patients at an early stage with convenient cost and better accuracy.


1 October 2021 in Immunogenetics
Verified
Journal Article
Open access
PDF file
Kuljeet SinghKuljeet Singh
Kuljeet Singh
SKSachin Kumar
Sachin Kumar
SSSourabh Shastri
Sourabh Shastri
Amrit SudershanAmrit Sudershan
Amrit Sudershan
VMVibhakar Mansotra
Vibhakar Mansotra
The catastrophic phase of Covid-19 turns the table over with the spread of its disastrous transmission network throughout the world. Covid-19 associated with mucormycosis fungal infection accompanied by opportunistic comorbidities have emerged the myriad of complications and manifestations. We searched the electronic databases of Google Scholar, PubMed, Springer, and Elsevier until June 05, 2021, using keywords. We retrieved the details of confirmed and suspected mucormycosis patients associated with Covid-19. We analyzed the case reports, treatment given for Covid-19, steroids used, associated comorbidities, mucormycosis site involved, and patients survived or dead. Overall, 102 patients of mucormycosis associated with Covid-19 have been reported from India. Mucormycosis was predominant in males (69.6%) rather than females (19.6%), and most of the patients were active Covid-19 cases (70.5%). Steroids were mostly used (68.6%) for the treatment of Covid-19 followed by remdesivir (10.7%). Patients were suffering from diabetes mellitus (88.2%) and severe diabetic ketoacidosis (11.7%). Mucormycosis affects the sino-nasal (72.5%), orbit (24.5%), central nervous system (18.6%), and maxillary necrosis (13.7%) of the patients. The Mortality rate was recorded as 23.5%, and recovery rate was 2.9%. Diabetes mellitus cases are highest in India as compared to other countries, and prevalent use of steroids with the background of Covid-19 becomes an opportunistic environment for mucormycosis fungal infection to survive.